Cytochrome P450-dependent oxidation is a pathway for all-trans-retinoi
c acid (all-trans-RA) catabolism. Induction of this catabolic pathway
was studied in MCF-7 breast cancer cells. MCF-7 cells showed low const
itutive all-trans-RA catabolism. Concentration-dependent induction was
obtained by preincubation of the cells with all-trans-RA (10(-9) to 1
0(-6) M). Onset of induction was fast, being detectable within 60 min,
with maximal induction (45-fold) obtained after 16 h. Enzymatic chara
cterization of induced all-trans-RA catabolism showed an estimated K-m
value (Michaelis-Menten constant) of 0.33 mu M and a V-max value (max
imal velocity of an enzyme-catalysed reaction) of 54.5 fmol polar all-
trans-RA metabolites 10(6) cells(-1) h(-1). These kinetic parameters r
epresent the overall formation of polar metabolites from all-trans-RA.
Induction of all-trans-RA catabolism was also obtained with other ret
inoids, CH55 >> 19-cis-RA = all-trans-RA > 9-cis-RA > 4-keto-all-trans
-RA > 4-keto-13-cis-RA > retinol. The potency of the retinoids to indu
ce all-trans-RA catabolism was correlated to their retinoic acid recep
tor affinity (Crettaz et al, 1990; Repa et al, 1990; Sani et al, 1990)
. Induction of all-trans-RA catabolism was inhibited by actinomycin D.
Furthermore, all-trans-RA did not increase cytosolic retinoic acid-bi
nding protein (CRABP) mRNA levels. These data suggest that induction o
f all-trans-RA catabolism in MCF-7 cells is a retinoic acid receptor-m
ediated gene transcriptional event. Induced all-trans-RA catabolism wa
s inhibited by various retinoids with decreasing potency in the order:
all-trans-RA > 4-keto-all-trans-RA > 13-cis-RA > 9-cis-RA > 4-keto-19
-cis-RA > retinol > CH55. The antitumoral compound liarozole-fumarate
inhibited all-trans-RA catabolism with a potency similar to that of al
l-trans-RA.